» Articles » PMID: 23922231

A Defective Krab-domain Zinc-finger Transcription Factor Contributes to Altered Myogenesis in Myotonic Dystrophy Type 1

Abstract

Myotonic dystrophy type 1 (DM1) is an RNA-mediated disorder caused by a non-coding CTG repeat expansion that, in particular, provokes functional alteration of CUG-binding proteins. As a consequence, several genes with misregulated alternative splicing have been linked to clinical symptoms. In our search for additional molecular mechanisms that would trigger functional defects in DM1, we took advantage of mutant gene-carrying human embryonic stem cell lines to identify differentially expressed genes. Among the different genes found to be misregulated by DM1 mutation, one strongly downregulated gene encodes a transcription factor, ZNF37A. In this paper, we show that this defect in expression, which derives from a loss of RNA stability, is controlled by the RNA-binding protein, CUGBP1, and is associated with impaired myogenesis-a functional defect reminiscent of that observed in DM1. Loss of the ZNF37A protein results in changes in the expression of the subunit α1 of the receptor for the interleukin 13. This suggests that the pathological molecular mechanisms linking ZNF37A and myogenesis may involve the signaling pathway that is known to promote myoblast recruitment during development and regeneration.

Citing Articles

Circulating cell-free DNA methylation profiles as noninvasive multiple sclerosis biomarkers: A proof-of-concept study.

Fu H, Huang K, Zhu W, Zhang L, Bandaru R, Wang L medRxiv. 2025; .

PMID: 40034794 PMC: 11875267. DOI: 10.1101/2025.02.14.25322180.


Induced Pluripotent Stem Cells to Understand Mucopolysaccharidosis. I: Demonstration of a Migration Defect in Neural Precursors.

Lito S, Sidibe A, Ilmjarv S, Burda P, Baumgartner M, Wehrle-Haller B Cells. 2020; 9(12).

PMID: 33287330 PMC: 7761689. DOI: 10.3390/cells9122593.


Pluripotent Stem Cell-Based Drug Screening Reveals Cardiac Glycosides as Modulators of Myotonic Dystrophy Type 1.

Maury Y, Poydenot P, Brinon B, Lesueur L, Gide J, Roqueviere S iScience. 2019; 11:258-271.

PMID: 30639849 PMC: 6327858. DOI: 10.1016/j.isci.2018.12.019.


Myotonic Dystrophy and Developmental Regulation of RNA Processing.

Thomas J, Oliveira R, Sznajder L, Swanson M Compr Physiol. 2018; 8(2):509-553.

PMID: 29687899 PMC: 11323716. DOI: 10.1002/cphy.c170002.


Staufen1s role as a splicing factor and a disease modifier in Myotonic Dystrophy Type I.

Bondy-Chorney E, Crawford Parks T, Ravel-Chapuis A, Jasmin B, Cote J Rare Dis. 2016; 4(1):e1225644.

PMID: 27695661 PMC: 5027583. DOI: 10.1080/21675511.2016.1225644.